Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells (vol 73, 163, 2024)

被引：0
|
作者：
El-Seraf, Ibrahim [1 ,2 ]
Nilsson, Isabella Micallef [1 ]
Moter, Alina [1 ]
Duan, Zhe [1 ]
Mattsson, Jonas [1 ,3 ,4 ]
Magalhaes, Isabelle [1 ,5 ]
机构：
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Ajman Univ, Coll Med, Basic Med Sci Dept, Ajman, U Arab Emirates
[3] Univ Toronto, Gloria & Seymour Epstein Chair Cell Therapy & Tran, Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[5] Karolinska Univ Hosp, Dept Immunol & Transfus Med, Stockholm, Sweden
来源：
CANCER IMMUNOLOGY IMMUNOTHERAPY | 2024年 / 73卷 / 11期
关键词：
D O I：
10.1007/s00262-024-03813-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Impact of fludarabine and treosulfan on ovarian tumor cells and mesothelin chimeric antigen receptor T cells
    El-Serafi, Ibrahim
    Nilsson, Isabella Micallef
    Moter, Alina
    Duan, Zhe
    Mattsson, Jonas
    Magalhaes, Isabelle
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (09)
  • [2] Anti-mesothelin chimeric antigen receptor T cells in patients with epithelial ovarian cancer.
    Tanyi, Janos Laszlo
    Haas, Andrew R.
    Beatty, Gregory Lawrence
    Stashwick, Caitlin Jane
    O'Harat, Mark H.
    Morgan, Mark Aloysuis
    Porter, David L.
    Melenhorst, Jan J.
    Plesa, Gabriela
    Lacey, Simon F.
    June, Carl H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
    Lv, Jiang
    Zhao, Ruocong
    Wu, Di
    Zheng, Diwei
    Wu, Zhiping
    Shi, Jingxuan
    Wei, Xinru
    Wu, Qiting
    Long, Youguo
    Lin, Simiao
    Wang, Suna
    Wang, Zhi
    Li, Yang
    Chen, Yantao
    He, Qing
    Chen, Suimin
    Yao, Huihui
    Liu, Zixia
    Tang, Zhaoyang
    Yao, Yao
    Pei, Duanqing
    Liu, Pentao
    Zhang, Xuchao
    Zhang, Zhenfeng
    Cui, Shuzhong
    Chen, Ren
    Li, Peng
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
  • [4] Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
    Jiang Lv
    Ruocong Zhao
    Di Wu
    Diwei Zheng
    Zhiping Wu
    Jingxuan Shi
    Xinru Wei
    Qiting Wu
    Youguo Long
    Simiao Lin
    Suna Wang
    Zhi Wang
    Yang Li
    Yantao Chen
    Qing He
    Suimin Chen
    Huihui Yao
    Zixia Liu
    Zhaoyang Tang
    Yao Yao
    Duanqing Pei
    Pentao Liu
    Xuchao Zhang
    Zhenfeng Zhang
    Shuzhong Cui
    Ren Chen
    Peng Li
    [J]. Journal of Hematology & Oncology, 12
  • [5] Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer
    Cao, Bihui
    Liu, Manting
    Wang, Lu
    Liang, Baoxia
    Feng, Yunfei
    Chen, Xiaopei
    Shi, Yuanyuan
    Zhang, Jinling
    Ye, Xiaodie
    Tian, Yu
    Zhi, Cheng
    Li, Junping
    Lian, Hui
    Wu, Qingde
    Zhang, Zhenfeng
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 524 (01) : 96 - 102
  • [6] Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
    O'Hara, Mark
    Stashwick, Caitlin
    Haas, Andrew R.
    Tanyi, Janos L.
    [J]. IMMUNOTHERAPY, 2016, 8 (04) : 449 - 460
  • [7] Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
    Le, Quy
    Castro, Sommer
    Tang, Thao
    Loeb, Anisha M.
    Hylkema, Tiffany
    McKay, Cyd Nourigat
    Perkins, LaKeisha
    Srivastava, Shivani
    Call, Lindsey
    Smith, Jenny
    Leonti, Amanda
    Ries, Rhonda
    Pardo, Laura
    Loken, Michael R.
    Correnti, Colin
    Fiorenza, Salvatore
    Turtle, Cameron J.
    Riddell, Stanley
    Tarlock, Katherine
    Meshinchi, Soheil
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (20) : 5718 - 5730
  • [8] Chimeric antigen receptor T cells
    Bories, Pierre
    Ysebaert, Loic
    [J]. BULLETIN DU CANCER, 2021, 108 (10) : S55 - S64
  • [9] Chimeric Antigen Receptor T Cells in Tumor Immunology: Opportunities and Challenges
    Huang, Yingying
    Wang, Yiwei
    Duan, Siliang
    Hu, Zixi
    He, Jian
    Huang, Yong
    Lu, Xiaoling
    Zhao, Yongxiang
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2016, 16 (12) : 12071 - 12085
  • [10] Tumor-targeting domains for chimeric antigen receptor T cells
    Bezverbnaya, Ksenia
    Mathews, Ashish
    Sidhu, Jesse
    Helsen, Christopher W.
    Bramson, Jonathan L.
    [J]. IMMUNOTHERAPY, 2017, 9 (01) : 33 - 46
12345